B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics. Issue 1 (23rd September 2021)

• Record Type: Journal Article
• Authors: Felten, Renaud; Duret, Pierre-Marie; Bauer, Elodie; Sedmak, Nathanael; Djossou, Julien H; Bensalem, Massiva; Ardizzone, Marc; Geoffroy, Marion; Fan, Angelique; Couderc, Marion; Salmon, Jean Hugues; Messer, Laurent; Javier, Rose-Marie; Meyer, Alain; Chatelus, Emmanuel; Sordet, Christelle; Pijnenburg, Luc; Fort, Jérémy; Rinagel, Marina; Walther, Julia; Fabre, Cassandre; Arnaud, Laurent; Sibilia, Jean; Meyer, Nicolas; Berenbaum, Francis; Chary-Valckenaere, isabelle; Soubrier, Martin; Sellam, Jérémie; Gottenberg, Jacques-Eric
• Is Part Of: Annals of the rheumatic diseases. Volume 81:Issue 1(2022)
• Page Start: 143
• Page End: 145
• Publication Date: 2021-09-23
• Subjects: Covid-19 -- Biological Therapy -- Therapeutics -- Rituximab; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2021-220549
• Languages: English
• ISSNs: 0003-4967